Medovex Corp Insiders
HCYTDelisted Stock | USD 2.21 0.00 0.00% |
Medovex Corp employs about 8 people. The company is managed by 4 executives with a total tenure of roughly 10 years, averaging almost 2.0 years of service per executive, having 2.0 employees per reported executive. Breaking down Medovex Corp's management performance can provide insight into the firm performance.
Michael Yurkowsky CEO CEO Director |
Medovex |
Medovex Corp Management Team Effectiveness
The company has return on total asset (ROA) of (3.4756) % which means that it has lost $3.4756 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (4.5969) %, meaning that it created substantial loss on money invested by shareholders. Medovex Corp's management efficiency ratios could be used to measure how well Medovex Corp manages its routine affairs as well as how well it operates its assets and liabilities.Medovex Corp Workforce Comparison
Medovex Corp is rated below average in number of employees category among its peers. The total workforce of Biotechnology industry is currently estimated at about 1,544. Medovex Corp maintains roughly 8.0 in number of employees contributing less than 1% to stocks in Biotechnology industry.
Medovex Corp Notable Stakeholders
A Medovex Corp stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Medovex Corp often face trade-offs trying to please all of them. Medovex Corp's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Medovex Corp's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Michael Yurkowsky | CEO Director | Profile | |
CPA CPA | Controller Officer | Profile | |
Jeremy Daniel | Chief Officer | Profile | |
Tanya Rhodes | Chief Officer | Profile |
About Medovex Corp Management Performance
The success or failure of an entity such as Medovex Corp often depends on how effective the management is. Medovex Corp management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Medovex management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Medovex management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
H-CYTE, Inc., a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders in the United States. It has a product supply agreement with Rion, LLC to develop and distribute a biologic for chronic obstructive pulmonary disease. H CYTE operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 8 people.
The data published in Medovex Corp's official financial statements typically reflect Medovex Corp's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Medovex Corp's quantitative information. For example, before you start analyzing numbers published by Medovex accountants, it's essential to understand Medovex Corp's liquidity, profitability, and earnings quality within the context of the Healthcare space in which it operates.
Please note, the imprecision that can be found in Medovex Corp's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Medovex Corp. Check Medovex Corp's Beneish M Score to see the likelihood of Medovex Corp's management manipulating its earnings.
Medovex Corp Workforce Analysis
Traditionally, organizations such as Medovex Corp use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Medovex Corp within its industry.Medovex Corp Manpower Efficiency
Return on Medovex Corp Manpower
Revenue Per Employee | 201.4K | |
Revenue Per Executive | 402.9K | |
Net Loss Per Employee | 599.9K | |
Net Loss Per Executive | 1.2M | |
Working Capital Per Employee | 416.2K | |
Working Capital Per Executive | 832.3K |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Consideration for investing in Medovex OTC Stock
If you are still planning to invest in Medovex Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medovex Corp's history and understand the potential risks before investing.
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
CEOs Directory Screen CEOs from public companies around the world | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |